Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel
Chinese Chemical Letters · 2026-05 · 37 (5) · 111350
DOI: 10.1016/j.cclet.2025.111350 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Yaqi Li und 11 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Anhui University of Chinese Medicine, Department of Education of Liaoning Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- China Postdoctoral Science Foundation
- Anhui University of Chinese Medicine
- Department of Education of Liaoning Province
- Liaoning Revitalization Talents Program
- Key Research and Development Program of Liaoning Province
Zitieren
APA
Li, Y., Sun, Y., Yan, Q., Wang, W., Wang, S., Wang, Q., Wang, D., Yuan, J., Sun, J., He, Z., Li, Z., & Sun, B. (2026). Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel. Chinese Chemical Letters, 37(5), 111350. https://doi.org/10.1016/j.cclet.2025.111350
Vancouver
Li Y, Sun Y, Yan Q, Wang W, Wang S, Wang Q, et al. Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel. Chinese Chemical Letters. 2026;37(5):111350. doi:10.1016/j.cclet.2025.111350
BibTeX
@article{Li2026,
author = {Li, Yaqi and Sun, Yixin and Yan, Qinglong and Wang, Wenjing and Wang, Shuo and Wang, Qing and Wang, Danping and Yuan, Jun and Sun, Jin and He, Zhonggui and Li, Zhenbao and Sun, Bingjun},
title = {Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel},
journal = {Chinese Chemical Letters},
year = {2026},
volume = {37},
number = {5},
pages = {111350},
doi = {10.1016/j.cclet.2025.111350}
}
EUVIMED